On the HCPLive Hidradenitis Suppurativa condition center page, audiences can find a variety of coverage mediums for medical news and updates, including articles, video interviews, podcasts, and breaking news on dermatology research, treatment, and drug development.
October 17th 2024
This analysis was conducted to evaluate whether genetic risk of hidradenitis suppurativa was linked to greater risk of future cardiometabolic disease.
September 24th 2024
September 23rd 2024
Coping Methods, Lack of Support Are Predictors of Self-Stigma for Patients with Skin Disease
These findings resulted from a systematic literature review highlighting the impact of stigma and lack of support on self-image for patients with eczema, psoriasis, HS, and other conditions.
Izokibep Data from Psoriatic Arthritis, Hidradenitis Suppurativa Support Phase 3 Development
March 14th 2024On March 11, 2024, Acelyrin Inc. announced new positive data from clinical trial programs examining their IL-17A inhibitor izokibep in patients psoriatic arthritis and hidradenitis suppurativa.